Publications found:
512,290
Sort by:
The 2027-2032 World Outlook for Human Platelet Lysates
US$ 1,195.00
This study covers the world outlook for human platelet lysates across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Human Primary Cells
US$ 1,195.00
This study covers the world outlook for human primary cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Human Serum Albumin
US$ 1,195.00
This study covers the world outlook for human serum albumin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Humanized Liver Mice Models
US$ 1,195.00
This study covers the world outlook for humanized liver mice models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Humanized Mouse Models
US$ 1,195.00
This study covers the world outlook for humanized mouse models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hunter Syndrome Treatments
US$ 1,195.00
This study covers the world outlook for Hunter syndrome treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Hyaluronidase
US$ 1,195.00
This study covers the world outlook for hyaluronidase across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Hybrid Imaging
US$ 1,195.00
This study covers the world outlook for hybrid imaging across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Hybrid Operating Rooms
US$ 1,195.00
This study covers the world outlook for hybrid operating rooms across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hydroxyapatite
US$ 1,195.00
This study covers the world outlook for hydroxyapatite across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Hydroxychloroquine
US$ 1,195.00
This study covers the world outlook for hydroxychloroquine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Hydroxychloroquine Sulphates
US$ 1,195.00
This study covers the world outlook for hydroxychloroquine sulphates across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Hypercalcemia Treatments
US$ 1,195.00
This study covers the world outlook for hypercalcemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Hyperhidrosis Treatments
US$ 1,195.00
This study covers the world outlook for hyperhidrosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Hyperimmune Globulins
US$ 1,195.00
This study covers the world outlook for hyperimmune globulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Hyperlipidemia Drugs
US$ 1,195.00
This study covers the world outlook for hyperlipidemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hypodermic Needles
US$ 1,195.00
This study covers the world outlook for hypodermic needles across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Hypothyroidism Treatments
US$ 1,195.00
This study covers the world outlook for hypothyroidism treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
288 pages
The 2027-2032 World Outlook for Hysteroscopes
US$ 1,195.00
This study covers the world outlook for hysteroscopes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Hysteroscopy Instruments
US$ 1,195.00
This study covers the world outlook for hysteroscopy instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Ileostomy
US$ 1,195.00
This study covers the world outlook for ileostomy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages
The 2027-2032 World Outlook for Iloprost Drugs
US$ 1,195.00
This study covers the world outlook for iloprost drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Image-Guided Therapy Systems
US$ 1,195.00
This study covers the world outlook for image-guided therapy systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Immortalized Cell Lines
US$ 1,195.00
This study covers the world outlook for immortalized cell lines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
